TinyGemsBreaks Archive - Page 30 of 140

WednesdayOct 02, 2024 2:18 pm

TinyGemsBreaks – Global Capital Network Names IBN as Media Sponsor for This Month’s GCN Investor Expo

Global Capital Network (“GCN”), an industry-leading agency with a strong track record of producing highly successful financial events, has engaged IBN as an official media sponsor of its upcoming GCN Investor Expo. The event is slated for Oct. 17, 2024, in Newport Beach, California. The company also noted that InvestorWire is an official newswire of the one-day event. An innovative corporate communications firm and content distributor, IBN will provide key coverage of this month’s GCN Investor Expo, an elite event designed to offer best-in-class educational, investing and high-powered networking opportunities. The event will bring together more than 400 investors, founders, brokers,…

TuesdayOct 01, 2024 10:11 am

TinyGemsBreaks – Nightfood Holdings Inc. (NGTF) Signs LOI to Acquire Renowned LA Cooking School

Nightfood Holdings (OTCQB: NGTF), an acquisition and development holding company, has signed a letter of intent (“LOI”) outlining the acquisition of Stratford Education Group Inc., which is known as the Los Angeles Cooking School. The school is widely recognized for its culinary training and education programs with planned classes that will also include state-of-the-art training for hospitality and foodservice operators wanting to leverage robotics and automation solutions. Nightfood plans to establish the Los Angeles Cooking School as the world-class leader in integration of food preparation automation, robotics and artificial intelligence (“AI”). “The acquisition of the Los Angeles Cooking School marks…

FridaySep 27, 2024 3:20 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that it had received approval from an independent review board for its planned human pilot study #3. The approval signals that the company can begin the study, which aims to investigate the first ever DehydraTECH-processed version of tirzepatide, a dual action glucagon-like peptide (“GLP-1”) + glucose-dependent insulinotropic peptide (“GIP”), in an oral dose format. Tirzepatide is approved for use in the U.S. under the Eli Lilly(TM)-owned Zepbound(R) and Mounjaro(R) brands. Lexaria plans to begin subject enrollment shortly, with the company expecting to make an announcement as…

ThursdaySep 26, 2024 12:35 pm

TinyGemsBreaks – Audius Announces ‘Game-Changing’ Music Marketplace Monetization Option Going Public

Audius, the largest decentralized music community and discovery platform for artists and their fans, is expanding the beta version of its game-changing monetization feature to make it public. According to the announcement, any artist in the world can now join the music marketplace, which is designed to enable artists to set their own terms and control the pricing of their music while allowing fans to support their favorite artists with direct payments. Fans can make payments using their credit cards, and artists can convert the payment to any currency of their choice. Numerous independent record labels and distributors have already…

WednesdaySep 25, 2024 12:20 pm

TinyGemsBreaks – Ederra CEO Featured on Health and Wellness with KAJ Podcast

Ederra, a farm-to-body wellness brand that combines nature and cutting-edge science to create innovative, functional supplements for brain and body longevity, is featured in the latest release of the Health and Wellness with KAJ Podcast. Vladi Delsoglio, Founder and CEO of Ederra, joined host Khudania Ajay to discuss his and the company’s backgrounds, the power of functional superfoods, sustainable wellness practices, and transparency in the supplement business. Vladi also talked about plans to expand the company’s product line and sales channels, as well as how Ederra is differentiated from the competition. “When we started, it took us a year to…

TuesdaySep 24, 2024 11:15 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Shares Video Update from CEO

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared a video update to shareholders provided by CEO and Chairman David Michery. In the video, Michery provides a detailed overview of the company’s recent progress, including sales and distribution expansion and financial performance. According to the update, the company’s sales activities with existing and new companies have resulted in new sales opportunities and vehicle orders received and or completed. Additionally, Mullen has secured financing to support sales growth through a $100 million preferred instrument and a $150 million fully available equity line. The update also highlighted Bollinger Motors’…

MondaySep 23, 2024 1:42 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), Subsidiary Celebrate Production of B4 Electric Truck, CEO to Release Shareholder Update Video

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, and its subsidiary, Bollinger Motors, are announcing a major milestone. According to the announcement, the first customer-ready B4 electric truck rolled off the production line in Livonia, Michigan, last week. Employees, suppliers and government officials gathered on Sept. 20, 2024, to celebrate the production of the first customer-ready, all-electric Class 4 Bollinger B4 Chassis Cab. The vehicle, which is produced in partnership with Roush Industries, is entirely assembled in the United States. “Robert Bollinger and his team made a gutsy call two years ago to pivot to an entirely different market…

MondaySep 23, 2024 11:20 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that CEO John Climaco will present at the 24th Annual Biotech in Europe Forum. The presentation is scheduled for Wednesday, September 25, 2024, at 1:55 p.m. CEST in Basel, Switzerland. Additionally, management will participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. To view the full press release, visit https://ibn.fm/220Xp About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing…

FridaySep 20, 2024 3:18 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has reported positive interim results from an animal study on diabetes. This milestone best showcases the potential of its patented technology in not only addressing diabetes and obesity. Recently, the company announced the dosing completion of its human pilot study #2, GLP-1-H24-2, which sought to explore effective oral delivery of GLP-1 drugs. Some evaluated aspects included side effects, blood levels of…

FridaySep 20, 2024 1:39 pm

TinyGemsBreaks – SBC Medical Group Holdings Inc. (NASDAQ: SBC) Completes Business Combination with Pono Capital Two, Begins Trading on Nasdaq

SBC Medical Group Holdings Inc. (NASDAQ: SBC), a global provider of cosmetic treatment management services, has successfully completed its business combination with Pono Capital Two, which was approved on August 23, 2024. Following the merger's closure on September 17, 2024, SBC Medical's shares and warrants began trading on Nasdaq under the ticker symbols ‘SBC’ and ‘SBCWW,’ respectively. The company plans to utilize the new capital to drive expansion in the U.S. and Southeast Asia, while continuing to strengthen its established presence in Japan. “We are focused on providing premium care and value to our customers and their patients through transformative…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks